Common Contracts
18 similar null contracts by Oxford Lane Capital Corp., Oxford Square Capital Corp., Cushing MLP Total Return Fund, others
87,000,000 Principal Amount OXFORD LANE CAPITAL CORP.Oxford Lane Capital Corp. • January 13th, 2022 • New York
Oxford Lane Capital Corp., a corporation incorporated under the laws of the State of Maryland (the “Fund”), is a non-diversified closed-end management investment company that has registered as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Fund proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) $87,000,000 in aggregate principal amount of its 5.00% Notes Due 2027 (the “Notes”). The Fund also proposes to sell to the several Underwriters up to an additional $13,000,000 aggregate principal amount of Notes (the “Additional Notes” and, together with the Notes, the “Securities”) if and to the extent that Ladenburg Thalmann & Co. Inc., as the representative of the Underwriters in the offering (the “Representative”), shall have determined to exercise, on behalf of the Underwriters, the right to purchase such Additional Notes granted to the Underwriters in Section 3 hereof. The Se
OXFORD SQUARE CAPITAL CORP.Oxford Square Capital Corp. • May 14th, 2021 • New York
Oxford Square Capital Corp., a corporation incorporated under the laws of the State of Maryland (the “Fund”), is a non-diversified closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Fund proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) $70,000,000 aggregate principal amount of its 5.50% Notes Due 2028 (the “Notes”). The Securities will be issued under an indenture dated as of April 12, 2017 by and between the Fund and U.S. Bank National Association, as trustee (the “Trustee”), as amended and supplemented by that certain Third Supplemental Indenture to be dated as of or about May 20, 2021 (such indenture, as amended and supplemented, the “Indenture”). The Fund also proposes to sell to the several Underwriters up to an additional $10,500,000 aggregate principal amount of Notes (the “Addition
87,000,000 Principal AmountOxford Lane Capital Corp. • March 11th, 2021 • New York
Oxford Lane Capital Corp., a corporation incorporated under the laws of the State of Maryland (the “Fund”), is a non-diversified closed-end management investment company that has registered as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Fund proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) $87,000,000 in aggregate principal amount of its 6.75% Notes Due 2031 (the “Notes”). The Fund also proposes to sell to the several Underwriters up to an additional $13,000,000 aggregate principal amount of Notes (the “Additional Notes” and, together with the Notes, the “Securities”) if and to the extent that Ladenburg Thalmann & Co. Inc., as the representative of the Underwriters in the offering (the “Representative”), shall have determined to exercise, on behalf of the Underwriters, the right to purchase such Additional Notes granted to the Underwriters in Section 3 hereof. The Se
3,500,000 Shares OXFORD LANE CAPITAL CORP. Series 2027 Term Preferred Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • February 7th, 2020 • New York
OXFORD SQUARE CAPITAL CORP. 6.25% Notes due 2026 UNDERWRITING AGREEMENTOxford Square Capital Corp. • April 3rd, 2019 • New York
2,500,000 Shares OXFORD LANE CAPITAL CORP. Series 2024 Term Preferred Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • June 7th, 2017 • New York
Oxford Lane Capital Corp., a corporation incorporated under the laws of the State of Maryland (the “Fund”), is a non-diversified closed-end management investment company that has registered as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Fund proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) 2,500,000 shares of a new Series 2024 Term Preferred Stock, $0.01 par value per share (the “Firm Shares”). The Fund also proposes to sell to the several Underwriters not more than an additional 375,000 shares of the new Series 2024 Term Preferred Stock, $0.01 par value per share (the “Additional Shares”) if and to the extent that Ladenburg Thalmann & Co. Inc., as the representative of the Underwriters in the offering (the “Representative”), shall have determined to exercise, on behalf of the Underwriters, the right to purchase such Additional Shares granted to the Underwriters in S
TICC CAPITAL CORP. UNDERWRITING AGREEMENTTICC Capital Corp. • April 12th, 2017 • New York
TICC Capital Corp., a corporation incorporated under the laws of the State of Maryland (the “Fund”), is a non-diversified closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Fund proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) $57,500,000 aggregate principal amount of its 6.50% notes due March 30, 2024 (the “Notes”). The Securities will be issued under an indenture to be dated as of April 12, 2017 by and between the Fund and U.S. Bank National Association, as trustee (the “Trustee”), as amended and supplemented by that certain First Supplemental Indenture to be dated April 12, 2017 (such indenture, as amended and supplemented, the “Indenture”). The Fund also proposes to sell to the several Underwriters up to an additional $8,625,000 aggregate principal amount of Notes (the “Additional Note
1,224,490 Shares OXFORD LANE CAPITAL CORP. Series 2023 Term Preferred Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • June 19th, 2015 • New York
1,800,000 Shares OXFORD LANE CAPITAL CORP. Common Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • June 4th, 2015 • New York
1,000,000 Shares OXFORD LANE CAPITAL CORP. Series 2024 Term Preferred Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • November 21st, 2014 • New York
1,120,000 Shares OXFORD LANE CAPITAL CORP. Series 2024 Term Preferred Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • May 30th, 2014 • New York
2,800,000 Shares OXFORD LANE CAPITAL CORP. Common Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • March 12th, 2014 • New York
1,625,000 Shares OXFORD LANE CAPITAL CORP. Series 2023 Term Preferred Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • November 14th, 2013 • New York
800,000 Shares OXFORD LANE CAPITAL CORP. Series 2023 Term Preferred Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • June 14th, 2013 • New York
600,000 Shares OXFORD LANE CAPITAL CORP. Preferred Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • November 20th, 2012 • New York
Form of Underwriting Agreement] [ ] Shares OXFORD LANE CAPITAL CORP. Common Stock, $0.01 par value per Share UNDERWRITING AGREEMENTOxford Lane Capital Corp. • October 5th, 2012 • New York
Oxford Lane Capital Corp., a corporation incorporated under the laws of the State of Maryland (the “Fund”), is a non-diversified closed-end management investment company that has registered as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Fund proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) [ ] shares of common stock, $0.01 par value per share (the “Firm Shares”). The Fund also proposes to sell to the several Underwriters not more than an additional [ ] shares of common stock, $0.01 par value per share (the “Additional Shares”) if and to the extent that [ ], as the representative of the Underwriters in the offering (the “Representative”), shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares granted to the Underwriters in Section 3 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to a
6,000,000 Shares GSV CAPITAL CORP. Common Stock, $0.01 par value per Share UNDERWRITING AGREEMENTGSV Capital Corp. • May 11th, 2012 • New York
Citigroup Global Markets Inc. As Representative of the several Underwriters named in Schedule I attached hereto, 388 Greenwich Street
6,000,000 Shares THE CUSHING MLP TOTAL RETURN FUND Common Shares of Beneficial Interest, $0.001 par value per Share UNDERWRITING AGREEMENTCushing MLP Total Return Fund • February 25th, 2011 • New York
Based upon and subject to the foregoing, we are of the opinion that under current U.S. federal income tax law, although the discussion set forth in the Base Prospectus under the heading “Tax Matters,” as supplemented by the Prospectus Supplement, does not purport to discuss all possible U.S. federal income tax consequences of the purchase, ownership or disposition of the Shares, such discussion constitutes, in all material respects, a fair and accurate summary of the U.S. federal income tax consequences that are anticipated to be material to holders who purchase the Shares pursuant to the Prospectus, subject to the qualifications set forth in such discussion.
